Trials / Terminated
TerminatedNCT00902785
A Study Of Early Markers Of Choroidal Neovascularization
A Two-Year Exploratory, Observational, Non-Interventional Multicenter Study To Identify Early Markers Of Choroidal Neovascularization In Fellow Eyes Of Patients With Neovascular AMD In One Eye
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Identify early markers of choroidal neovascularization (CNV) in the fellow eye of a patient with CNV in the other eye due to age-related macular degeneration with the expectation of being able to identify patients in need of intervention.
Detailed description
CNV in one eye and dry AMD in the other
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no drug | observational no drug |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-05-15
- Last updated
- 2010-11-10
Locations
3 sites across 3 countries: Italy, Portugal, United Kingdom
Source: ClinicalTrials.gov record NCT00902785. Inclusion in this directory is not an endorsement.